Literature DB >> 7474140

Herpes simplex virus trans-regulatory protein ICP27 stabilizes and binds to 3' ends of labile mRNA.

C R Brown1, M S Nakamura, J D Mosca, G S Hayward, S E Straus, L P Perera.   

Abstract

Previous work demonstrated that a herpes simplex virus type 1 (HSV-1) immediate-early function up-regulates beta interferon but not chloramphenicol acetyltransferase reporter genes driven by the strong simian virus 40 (SV40) or cytomegalovirus promoter-enhancer regions in both transient assays and stable cell lines. The different 3' mRNA stabilization and RNA-processing signals from these two reporter genes appeared to be primarily responsible for this phenomenon. We now report that the HSV-1 ICP27 itself is sufficient to stimulate both steady-state accumulation and increased half-life of beta interferon reporter gene mRNA. Furthermore, the ability to respond directly to cotransfected ICP27 can be transferred to chloramphenicol acetyltransferase reporter genes by replacement of their SV40-derived splicing and poly(A) signals with the 3' AU-rich and poly(A) RNA-processing signals from the normally highly labile beta interferon and c-myc mRNA species. ICP27 expressed in bacteria bound specifically to in vitro-generated RNA from both the beta interferon and c-myc intronless AU-rich 3' RNA-processing regions, but not to the SV40-derived early-region splice signal and poly(A) sequences. By site-specific mutagenesis, we also show that individual ICP27 C-terminal amino acid residues that are positionally conserved in ICP27 homologs in other herpesviruses (D-357, E-358, H-479, C-400, C-483, and C-488) are critical for trans-regulatory activity. Importantly, several of these positions match mutations that are known to be essential for the role of ICP27 in the early-to-late switch during the virus lytic cycle. Therefore, our findings support the notion that HSV ICP27 modulates gene expression posttranscriptionally in part by targeting RNA.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7474140      PMCID: PMC189640     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  69 in total

1.  Mutations in the activation region of herpes simplex virus regulatory protein ICP27 can be trans dominant.

Authors:  I L Smith; R E Sekulovich; M A Hardwicke; R M Sandri-Goldin
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

2.  Evidence that the herpes simplex virus immediate early protein ICP27 acts post-transcriptionally during infection to regulate gene expression.

Authors:  I L Smith; M A Hardwicke; R M Sandri-Goldin
Journal:  Virology       Date:  1992-01       Impact factor: 3.616

3.  The repressing and enhancing functions of the herpes simplex virus regulatory protein ICP27 map to C-terminal regions and are required to modulate viral gene expression very early in infection.

Authors:  L McMahan; P A Schaffer
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

4.  Genetic evidence for two distinct transactivation functions of the herpes simplex virus alpha protein ICP27.

Authors:  S A Rice; D M Knipe
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

Review 5.  Conserved structures and diversity of functions of RNA-binding proteins.

Authors:  C G Burd; G Dreyfuss
Journal:  Science       Date:  1994-07-29       Impact factor: 47.728

6.  The herpes simplex virus regulatory protein ICP27 contributes to the decrease in cellular mRNA levels during infection.

Authors:  M A Hardwicke; R M Sandri-Goldin
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

7.  UL69 of human cytomegalovirus, an open reading frame with homology to ICP27 of herpes simplex virus, encodes a transactivator of gene expression.

Authors:  M Winkler; S A Rice; T Stamminger
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

8.  Identification and characterization of Marek's disease virus genes homologous to ICP27 and glycoprotein K of herpes simplex virus-1.

Authors:  D Ren; L F Lee; P M Coussens
Journal:  Virology       Date:  1994-10       Impact factor: 3.616

9.  The EBV early gene product EB2 transforms rodent cells through a signalling pathway involving c-Myc.

Authors:  L Corbo; F Le Roux; A Sergeant
Journal:  Oncogene       Date:  1994-11       Impact factor: 9.867

10.  Promoter-independent activation of heterologous virus gene expression by the herpes simplex virus immediate-early protein ICP27.

Authors:  C J Chapman; J D Harris; M A Hardwicke; R M Sandri-Goldin; M K Collins; D S Latchman
Journal:  Virology       Date:  1992-02       Impact factor: 3.616

View more
  40 in total

1.  Herpesvirus mRNAs are sorted for export via Crm1-dependent and -independent pathways.

Authors:  T M Soliman; S J Silverstein
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

2.  Processing of alpha-globin and ICP0 mRNA in cells infected with herpes simplex virus type 1 ICP27 mutants.

Authors:  K S Ellison; S A Rice; R Verity; J R Smiley
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

3.  Identification of a domain in human immunodeficiency virus type 1 rev that is required for functional activity and modulates association with subnuclear compartments containing splicing factor SC35.

Authors:  D M D'Agostino; T Ferro; L Zotti; F Meggio; L A Pinna; L Chieco-Bianchi; V Ciminale
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

4.  Herpes simplex virus ICP27 is required for virus-induced stabilization of the ARE-containing IEX-1 mRNA encoded by the human IER3 gene.

Authors:  Jennifer A Corcoran; Wei-Li Hsu; James R Smiley
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

5.  UL54-null pseudorabies virus is attenuated in mice but productively infects cells in culture.

Authors:  Jennifer A Schwartz; Elizabeth E Brittle; Ashley E Reynolds; Lynn W Enquist; Saul J Silverstein
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

6.  Promoter- and cell-specific transcriptional transactivation by the Kaposi's sarcoma-associated herpesvirus ORF57/Mta protein.

Authors:  Diana Palmeri; Sophia Spadavecchia; Kyla Driscoll Carroll; David M Lukac
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

7.  Herpes simplex virus-1 infection causes the secretion of a type I interferon-antagonizing protein and inhibits signaling at or before Jak-1 activation.

Authors:  Karen E Johnson; David M Knipe
Journal:  Virology       Date:  2009-10-31       Impact factor: 3.616

8.  The role of herpes simplex virus ICP27 in the regulation of UL24 gene expression by differential polyadenylation.

Authors:  L E Hann; W J Cook; S L Uprichard; D M Knipe; D M Coen
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

9.  The Epstein-Barr virus nuclear protein SM is both a post-transcriptional inhibitor and activator of gene expression.

Authors:  V Ruvolo; E Wang; S Boyle; S Swaminathan
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

10.  Herpes simplex virus type 1 ICP27 induces p38 mitogen-activated protein kinase signaling and apoptosis in HeLa cells.

Authors:  Peter A Gillis; Laura H Okagaki; Stephen A Rice
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.